• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种小鼠肿瘤细胞系产生的纤溶酶原激活物活性的克隆异质性

Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.

作者信息

Brail L H, Hill R P

机构信息

Division of Experimental Therapeutics, Ontario Cancer Institute, Canada.

出版信息

Clin Exp Metastasis. 1995 Nov;13(6):439-52. doi: 10.1007/BF00118183.

DOI:10.1007/BF00118183
PMID:7586802
Abstract

Secretion of plasminogen activators (PA) has been shown to be an important method by which cells can initiate degradation of the extracellular matrix (ECM). In this study we have examined the PA production of two murine cell lines, KHT-LP1, a fibrosarcoma and SCC-VII, a squamous cell carcinoma, and have found a high degree of clonal heterogeneity. Our method for assaying PA activity measures the PA activity of small colonies of cells derived from single cells, using an in vitro fibrin/agarose PA assay in which colonies with PA activity form discernable 'halos' in the fibrin/agarose semisolid growth medium. When these small colonies of cells were disassociated and the component cells were reassayed for PA activity it was again found to be heterogeneous, suggesting that this property can be generated during the growth of the colonies. KHT-LP1 cells derived from single cell clones were assayed for PA activity to determine the rate at which this phenotype was produced. It was found that the rate of formation of the PA activity phenotype was 6.5 x 10(-6) events per cell generation. The component cells of colonies which initially demonstrated high PA activity produced more PA activity than the component cells of the colonies that had low PA activity. This suggests that some aspects of the phenotype may be more stable than others. To examine whether the addition of lethally irradiated cells could stabilize the phenotype we determined whether fibrin/agarose PA assays supplemented with lethally irradiated cells would reduce the heterogeneity of PA activity. The results indicated that the heterogeneity was not reduced, and there was an increase in the average amount of PA activity.

摘要

纤溶酶原激活剂(PA)的分泌已被证明是细胞启动细胞外基质(ECM)降解的一种重要方式。在本研究中,我们检测了两种小鼠细胞系KHT-LP1(一种纤维肉瘤细胞系)和SCC-VII(一种鳞状细胞癌细胞系)的PA产生情况,发现存在高度的克隆异质性。我们检测PA活性的方法是测量源自单细胞的小细胞集落的PA活性,采用体外纤维蛋白/琼脂糖PA检测法,其中具有PA活性的集落在纤维蛋白/琼脂糖半固体生长培养基中形成可识别的“晕圈”。当这些小细胞集落被解离,其组成细胞再次检测PA活性时,发现其仍然是异质性的,这表明这种特性可能在集落生长过程中产生。对源自单细胞克隆的KHT-LP1细胞进行PA活性检测,以确定该表型产生的速率。发现PA活性表型的形成速率为每细胞代6.5×10^(-6)事件。最初表现出高PA活性的集落的组成细胞比低PA活性集落的组成细胞产生更多的PA活性。这表明表型的某些方面可能比其他方面更稳定。为了研究添加经致死剂量照射的细胞是否能使表型稳定,我们确定在纤维蛋白/琼脂糖PA检测中添加经致死剂量照射的细胞是否会降低PA活性的异质性。结果表明异质性并未降低,且PA活性的平均量有所增加。

相似文献

1
Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.两种小鼠肿瘤细胞系产生的纤溶酶原激活物活性的克隆异质性
Clin Exp Metastasis. 1995 Nov;13(6):439-52. doi: 10.1007/BF00118183.
2
Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma.
Clin Exp Metastasis. 1989 Mar-Apr;7(2):243-50. doi: 10.1007/BF01787027.
3
In vitro urokinase type plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck.
Arch Otolaryngol Head Neck Surg. 1994 Sep;120(9):989-92. doi: 10.1001/archotol.1994.01880330067012.
4
Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.人鳞状癌细胞系通过纤溶酶原激活剂介导的内皮下细胞外基质降解
Cancer Commun. 1990;2(5):189-99.
5
Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro.
Gynecol Oncol. 1988 Sep;31(1):103-12. doi: 10.1016/0090-8258(88)90276-4.
6
Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.腺样囊性癌细胞的细胞外基质产生与降解:纤溶酶原激活物及其抑制剂在基质降解中的作用
Cancer Res. 1993 Jan 1;53(1):147-52.
7
Production of plasminogen activator by a primary HSV-2-induced hamster fibrosarcoma and its in vivo derived sublines.原发性单纯疱疹病毒2型诱导的仓鼠纤维肉瘤及其体内衍生亚系产生纤溶酶原激活物。
Cancer. 1986 Apr 15;57(8):1522-7. doi: 10.1002/1097-0142(19860415)57:8<1522::aid-cncr2820570814>3.0.co;2-o.
8
Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.成纤维细胞对正常角质形成细胞和SCC-4细胞中纤溶酶原激活的差异调节。
J Invest Dermatol. 1995 Mar;104(3):374-8. doi: 10.1111/1523-1747.ep12665844.
9
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.表达人尿激酶型纤溶酶原激活物的小鼠L细胞:对细胞外基质降解和侵袭的影响
J Cell Biol. 1989 Aug;109(2):915-25. doi: 10.1083/jcb.109.2.915.
10
Measurement of plasminogen activator activity from human fibrosarcoma cells by a new microassay.
Int J Cancer. 1987 Dec 15;40(6):823-9. doi: 10.1002/ijc.2910400620.

引用本文的文献

1
Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.暴露于低氧、葡萄糖饥饿和酸中毒环境:对小鼠肿瘤细胞侵袭能力的影响以及与组织蛋白酶(L + B)分泌的相关性。
Clin Exp Metastasis. 1997 Jan;15(1):19-25. doi: 10.1023/a:1018428105463.

本文引用的文献

1
Effect of lethally damaged tumor cells upon the development of admixed viable cells.致死性损伤的肿瘤细胞对混合的活细胞生长发育的影响。
J Natl Cancer Inst. 1958 Jun;20(6):1157-86.
2
Biology and biochemistry of proteinases in tumor invasion.肿瘤侵袭中蛋白酶的生物学与生物化学
Physiol Rev. 1993 Jan;73(1):161-95. doi: 10.1152/physrev.1993.73.1.161.
3
Prevention of metastasis by inhibition of the urokinase receptor.通过抑制尿激酶受体预防转移。
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5021-5. doi: 10.1073/pnas.90.11.5021.
4
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness.尿激酶与尿激酶受体:一个调节细胞迁移和侵袭的旁分泌/自分泌系统。
Bioessays. 1993 Feb;15(2):105-11. doi: 10.1002/bies.950150206.
5
Tumor cell procoagulant and urokinase expression in carcinoma of the ovary.
J Natl Cancer Inst. 1993 Aug 4;85(15):1225-30. doi: 10.1093/jnci/85.15.1225.
6
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.纤溶酶原激活剂、其抑制剂以及尿激酶受体在黑素细胞肿瘤进展的晚期出现。
Am J Pathol. 1994 Jan;144(1):70-81.
7
Tumor cell interactions with the extracellular matrix during invasion and metastasis.肿瘤细胞在侵袭和转移过程中与细胞外基质的相互作用。
Annu Rev Cell Biol. 1993;9:541-73. doi: 10.1146/annurev.cb.09.110193.002545.
8
Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.对表达重组纤溶酶原激活物抑制剂2的HT1080肉瘤细胞侵袭的抑制作用
Cancer Res. 1993 Dec 15;53(24):6051-7.
9
Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.纤溶酶原激活系统各成分在良性乳腺疾病和乳腺癌中的表达及定位
J Cell Biochem. 1993 Oct;53(2):135-44. doi: 10.1002/jcb.240530206.
10
Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells.通过与转移性肿瘤细胞直接接触诱导成纤维细胞92 kDa明胶酶/IV型胶原酶表达。
J Cell Sci. 1994 Feb;107 ( Pt 2):477-86. doi: 10.1242/jcs.107.2.477.